Company / Working Capital per Share
Sarepta Therapeutics Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$14.89
FY2025
5-year range
$14.89 / $27.10
FY2021-FY2025
Trend
-40.4%
vs FY2024
Sector context
#31 of 210
Health Care
What the data says
Sarepta Therapeutics's working capital per share of $14.89 is higher than 85% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $6.53 in FY2016 to $27.52 in FY2020.
Based on SEC 10-K filings.
14.89 in FY2025 with a 5-year CAGR of -11.6%. Top quartile in the Health Care sector.
Declined from $21.90 to $14.89 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Sector benchmark
-89.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 40.4% year-over-year.
- Ranks #31 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.89 | -40.4% |
| FY2024 | $24.98 | +14.1% |
| FY2023 | $21.90 | -1.6% |
| FY2022 | $22.25 | -17.9% |
| FY2021 | $27.10 | -1.5% |
| FY2020 | $27.52 | +62.4% |
| FY2019 | $16.94 | -12.4% |
| FY2018 | $19.33 | -7.2% |
| FY2017 | $20.82 | +218.8% |
| FY2016 | $6.53 | +70.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026